Top headlines: Call for emergency use of Covaxin; tax officers face heat

From Bharat Biotech applying for emergency use of Covaxin to super-rich buying luxury products online like never before, here are top headlines this morning

Bharat Biotech applies for emergency use authorisation for Covaxin

After Pfizer and Serum Institute of India, Hyderabad-based Bharat Biotech has applied for an emergency use authorisation for its investigational vaccine candidate, Covaxin, to the Indian regulator. The firm is conducting its Phase 3 trial, involving 26,000 participants. Read More

Serum set for deal with Centre soon; to supply vaccine at Rs 250 a dose

The biggest vaccine maker of the world, Serum Institute of India (SII), which has applied to the regulator for an emergency use authorisation (EUA) for the Covishield vaccine, is close to signing a supply